# Evaluation of Switching From Current cART to Triumeq With Adherence Support Will Enhance HIV Control in Vulnerable Populations

> **NCT02354053** · PHASE4 · COMPLETED · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 27 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Switch to Triumeq
- **BEHAVIORAL:** Adherence support + current ART

## Key facts

- **NCT ID:** NCT02354053
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2018-07-03
- **Final completion:** 2019-07-02
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2020-09-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02354053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02354053, "Evaluation of Switching From Current cART to Triumeq With Adherence Support Will Enhance HIV Control in Vulnerable Populations". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02354053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*